Protein C-ets-1 mRNA (ETS1 mRNA) (ETS1 mRNA)

ETS1 mRNA is the messenger RNA transcript of the ETS proto-oncogene 1, which encodes a founding member of the ETS family of transcription factors (UniProt P14921). This mRNA is a critical regulatory node in cellular biology, as its translation produces the ETS1 protein, which governs the expression of genes involved in angiogenesis, cell proliferation, and extracellular matrix remodeling (NCBI Gene ID 2113). In clinical oncology, elevated levels of ETS1 mRNA are associated with aggressive tumor phenotypes and poor prognosis in cancers such as breast, ovarian, and colorectal cancer, where it facilitates epithelial-mesenchymal transition (EMT) (Hahne et al., 2008). Therapeutic strategies targeting ETS1 mRNA, such as the DNAzyme ED5 or various siRNAs, aim to selectively degrade the transcript to prevent the synthesis of the ETS1 protein, thereby inhibiting tumor growth and metastasis (Zhang et al., 2004). Furthermore, ETS1 mRNA is implicated in the pathogenesis of systemic lupus erythematosus (SLE), where genetic variants in the ETS1 locus affect mRNA stability and expression, contributing to immune dysregulation (Pan et al., 2015). Targeting this mRNA offers a way to modulate transcription factor activity that is otherwise difficult to target with small molecules in both malignant and autoimmune contexts.

Other names

ETS proto-oncogene 1 mRNAc-ets-1 mRNAv-ets erythroblastosis virus E26 oncogene homolog 1 mRNA

Antisense-mediated mRNA degradation or translation inhibition